Drug Type Small molecule drug |
Synonyms RNO |
Target |
Mechanism PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H14Cl2F2N2O4 |
InChIKeyPCGSQNPMMSALEJ-UHFFFAOYSA-N |
CAS Registry292135-78-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Disease, Chronic Obstructive | Phase 1 | CN | 09 Dec 2022 |